ReadYourDNA

Pravastatin (Pravachol)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Pravastatin

What it is

Pravastatin is a statin: it blocks HMG-CoA reductase, the liver enzyme that makes cholesterol, so the liver takes more LDL cholesterol out of the blood. It is a milder statin that is hardly broken down by liver enzymes, so it has fewer interactions with other medicines. It is used to lower cholesterol and to reduce the chance of heart attack and stroke. It is sold as Pravachol, among other names.

How genes come into it

Because pravastatin is barely broken down by liver enzymes, its level depends mainly on SLCO1B1, the transporter that carries it into the liver. The common variant rs4149056 (in the *5 and *15 versions) weakens the transporter, so more pravastatin stays in the blood. CPIC has published a guideline on SLCO1B1 and pravastatin. Studies have also looked at genes linked to how much cholesterol falls, such as HMGCR, LDLR and KIF6, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Pravastatin. They sort people into groups by the gene copies they carry.

CPIC guideline: SLCO1B1. Normal Function · Poor Function · Increased Function · Decreased Function · Possible Decreased Function · Indeterminate. Strong. 2022.

What research found

Every published finding on gene variants and Pravastatin. Upload your DNA file to see which of these rows apply to you.

Rated evidence (36 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

SLCO1B1 rs4149056: Level 1A · replicated. Metabolism/PK. 13.

SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15: Level 1A · replicated. Metabolism/PK. 6.

SLCO1B1 rs4149056: Level 1A · replicated. Toxicity: statin-related myopathy. 3.

SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15: Level 1A · replicated. Toxicity: statin-related myopathy. 3.

Metabolism (17 findings)

Studies of how quickly the body processes this medication.

ABCC2 rs113646094: Genotype CG is associated with increased clearance of pravastatin in healthy individuals as compared to genotype CC.

SLC10A1 rs2296651: Allele A is associated with increased clearance of pravastatin in healthy individuals as compared to allele G.

SLCO1B1 SLCO1B1*1, SLCO1B1*15: SLCO1B1 *15 is associated with increased concentrations of pravastatin in healthy individuals as compared to SLCO1B1 *1/*1.

SLCO1B1 SLCO1B1*1, SLCO1B1*15: SLCO1B1 *15/*15 is associated with increased concentrations of pitavastatin or pravastatin in healthy individuals as compared to SLCO1B1 *1/*1.

Response (37 findings)

Studies of how well it worked in people carrying a variant.

ABCA1 rs12003906: Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele G.

ACE rs1799752: Genotype del/del is associated with response to pravastatin in people with non-hypercholesterolaemic patients scheduled for angioplasty as compared to genotypes ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC + ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del.

ACE rs4341: Genotypes CG + GG are associated with increased response to pravastatin as compared to genotype CC.

APOE rs7412: Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele T.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Baycol (Statins)

Crestor (Statins)

Lescol (Statins)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com